gastric-cancer

Documents about gastric-cancer

• Novel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric Tissue#900326ClinicalTrials.gov
• Performance of Endoscopic Submucosal Dissection According to the Sedation Method#902775ClinicalTrials.gov
• The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric#912781ClinicalTrials.gov
• Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity#903863ClinicalTrials.gov
• The Effect of Nutritional Counseling for Cancer Patients#873297ClinicalTrials.gov
• A Phase I Study of E7050 in Subjects With Solid Tumors#886633ClinicalTrials.gov
• Comparison Study of Brachytherapy and Endoscopic Stenting for Dysphagia in Esophago-Gastric Junction Cancer#829163ClinicalTrials.gov
• Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma#903560ClinicalTrials.gov
• Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659)#268032ClinicalTrials.gov
• Short-Term and Long-Term Outcomes of Robotic Gastrectomy for Gastric Cancer: A Single-Center, Single-Arm Prospective Study#465447OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Limited discriminative performance of endoscopic deep learning for Helicobacter pylori status assessment in gastric cancer patients: a retrospective study#482633HAL (France)
• Study to Evaluate the Safety and Efficacy of Tislelizumab in Combination With Zanidatamab as a 2nd Line in HER2-Positive Advanced Gastric Cancer in K-Umbrella Trial#838290ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract#226346ClinicalTrials.gov
• Laser Fluorescence in Cancer Surgical Treatment#871418ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer#398184ClinicalTrials.gov
• Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery#839840ClinicalTrials.gov
• Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy#398312ClinicalTrials.gov
• PRIORITY-CONNECT 2 Pilot Trial#894068ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)#887802ClinicalTrials.gov
• Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer#839519ClinicalTrials.gov
• Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery#888611ClinicalTrials.gov
• TaxXel: Taxotere and Xeloda in Esophageal Cancer#846506ClinicalTrials.gov
• Clinical Study of 68Ga Labeled HER2 Affibody Analogues#969391ClinicalTrials.gov
• Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas#158228ClinicalTrials.gov
• Effect of MSD on FCR Among Gastric Cancer Survivors#896925ClinicalTrials.gov
• A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma#802525ClinicalTrials.gov
• RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression#878328ClinicalTrials.gov
• A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2#892241ClinicalTrials.gov
• A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer#902240ClinicalTrials.gov
• Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer#908092ClinicalTrials.gov
• Integrated Care Pathway in Oncology (PASSION)#902625ClinicalTrials.gov
• A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer#843598ClinicalTrials.gov
• Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women#910017ClinicalTrials.gov
• Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors#123552ClinicalTrials.gov
• A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer#332745ClinicalTrials.gov
• Inverse Association between Dietary Iron Intake and Gastric Cancer: A Pooled Analysis of Case-Control Studies of the Stop Consortium#274668IRIS
• Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma#915019ClinicalTrials.gov
• Metabolic remodeling by circular RNAs in gastric tumorigenesis: From mechanisms to biomarker discovery (Review)#266494Europe PMC
• Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression#806247ClinicalTrials.gov
• XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma#873459ClinicalTrials.gov
• The Effect of Proton Pump Inhibitor and Polaprezinc Combination Therapy for Healing of Endoscopic Submucosal Dissection-induced Ulcer#888276ClinicalTrials.gov
• Perioperative Chemotherapy With Low-Dose Radiotherapy and Tislelizumab for Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma#894344ClinicalTrials.gov
• Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study#900545ClinicalTrials.gov
• CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy#363611ClinicalTrials.gov
• Screening of core targets for Di(2-ethylhexyl) Phthalate-related gastric cancer based on machine learning, molecular docking, and SHAP analysis#376009PLOS
• Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer#895186ClinicalTrials.gov
• Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer#992139ClinicalTrials.gov
• BReast CAncer Genes(BRCA) Expressions in Metastatic Gastric Cancer#901312ClinicalTrials.gov
• Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia#979164ClinicalTrials.gov
• Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors#201777ClinicalTrials.gov